Delivery Order SPE2DB25D3021-SPE2DB25FQYNY
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $27,434.77 and a completion date of May 14, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,638.72, is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,293.47, is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $26,316.91, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a medication, with a performance period through May 8, 2025. The contract is not set-aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $26,077.33 and a period of performance through March 29, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This is a $4,777.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for COSENTYX SNRDY 300MG DOSE-2PENML. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML, with a ceiling value of $14,259.25 and an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $14,014.80 and a performance period ending on May 13, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,910.45 contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has an ultimate completion date of May 12, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $11,868.44 and a period of performance through April 11, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...